Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 606

1.

THE DOSE AND DOSE-RATE EFFECTIVENESS FACTOR (DDREF).

Wakeford R, Azizova T, Dörr W, Garnier-Laplace J, Hauptmann M, Ozasa K, Rajaraman P, Sakai K, Salomaa S, Sokolnikov M, Stram D, Sun Q, Wojcik A, Woloschak G, Bouffler S, Grosche B, Kai M, Little MP, Shore RE, Walsh L, Rühm W.

Health Phys. 2019 Jan;116(1):96-99. doi: 10.1097/HP.0000000000000958. No abstract available.

PMID:
30489371
2.

[Significance of Endocrine Therapy for Unresected Primary Breast Cancer].

Kurata K, Kai M, Kubo M, Mori H, Yamada M, Nakafusa Y, Nakamura M.

Gan To Kagaku Ryoho. 2018 Nov;45(11):1645-1647. Japanese.

PMID:
30449855
3.

Interspecific formation of the antimicrobial volatile schleiferon.

Kai M, Effmert U, Lemfack MC, Piechulla B.

Sci Rep. 2018 Nov 15;8(1):16852. doi: 10.1038/s41598-018-35341-3.

4.

The Predicament of Gastrointestinal Bleeding in Patients with a Continuous Flow Left Ventricular Assist Device: Pathophysiology, Evaluation and Management.

Berg D, Lebovics E, Kai M, Spielvogel D.

Cardiol Rev. 2018 Oct 25. doi: 10.1097/CRD.0000000000000235. [Epub ahead of print]

PMID:
30365405
5.

Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance.

Ziemys A, Yokoi K, Kai M, Liu YT, Kojic M, Simic V, Milosevic M, Holder A, Ferrari M.

J Control Release. 2018 Dec 10;291:99-105. doi: 10.1016/j.jconrel.2018.10.014. Epub 2018 Oct 14.

PMID:
30332610
6.

Interspecies interaction of Serratia plymuthica 4Rx13 and Bacillus subtilis B2g alters the emission of sodorifen.

Kai M, Piechulla B.

FEMS Microbiol Lett. 2018 Nov 1;365(22). doi: 10.1093/femsle/fny253.

PMID:
30307482
7.

QOL-enhancing surgery for patients with HER2-positive metastatic breast cancer.

Kai M, Kubo M, Kawaji H, Kurata K, Mori H, Yamada M, Nakamura M.

BMJ Support Palliat Care. 2018 Sep 25. pii: bmjspcare-2018-001622. doi: 10.1136/bmjspcare-2018-001622. [Epub ahead of print]

PMID:
30254019
8.

Errata: Internal doses from radionuclides and their health effects following the Fukushima accident (J. Radiol. Prot. 2018 38 1253-68).

Ishikawa T, Matsumoto M, Sato T, Yamaguchi I, Kai M.

J Radiol Prot. 2018 Sep 21. doi: 10.1088/1361-6498/aae324. [Epub ahead of print]

PMID:
30238930
9.

DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling.

Ishiguro K, Kitajima H, Niinuma T, Ishida T, Maruyama R, Ikeda H, Hayashi T, Sasaki H, Wakasugi H, Nishiyama K, Shindo T, Yamamoto E, Kai M, Sasaki Y, Tokino T, Nakase H, Suzuki H.

Haematologica. 2018 Aug 31. pii: haematol.2018.191262. doi: 10.3324/haematol.2018.191262. [Epub ahead of print]

10.

Sodorifen Biosynthesis in the Rhizobacterium Serratia plymuthica Involves Methylation and Cyclization of MEP-Derived Farnesyl Pyrophosphate by a SAM-Dependent C-Methyltransferase.

von Reuss S, Domik D, Lemfack MC, Magnus N, Kai M, Weise T, Piechulla B.

J Am Chem Soc. 2018 Sep 19;140(37):11855-11862. doi: 10.1021/jacs.8b08510. Epub 2018 Sep 4.

PMID:
30133268
11.

Internal doses from radionuclides and their health effects following the Fukushima accident.

Ishikawa T, Matsumoto M, Sato T, Yamaguchi I, Kai M.

J Radiol Prot. 2018 Dec;38(4):1253-1268. doi: 10.1088/1361-6498/aadb4c. Epub 2018 Aug 20.

PMID:
30124199
12.

Usability of Intraoperative Fluorescence Imaging with Indocyanine Green During Laparoscopic Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage.

Yoshiya S, Minagawa R, Kamo K, Kasai M, Taketani K, Yukaya T, Kimura Y, Koga T, Kai M, Kajiyama K, Yoshizumi T.

World J Surg. 2018 Aug 13. doi: 10.1007/s00268-018-4760-1. [Epub ahead of print]

PMID:
30105635
13.

Extended Arch Procedures for Acute Type A Aortic Dissection: A Downstream Problem?

Lansman SL, Goldberg JB, Kai M, Malekan R, Spielvogel D.

Semin Thorac Cardiovasc Surg. 2018 Aug 3. pii: S1043-0679(18)30154-0. doi: 10.1053/j.semtcvs.2018.07.013. [Epub ahead of print]

PMID:
30077777
14.

Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1.

Nishiyama K, Maruyama R, Niinuma T, Kai M, Kitajima H, Toyota M, Hatanaka Y, Igarashi T, Kobayashi JI, Ogi K, Dehari H, Miyazaki A, Yorozu A, Yamamoto E, Idogawa M, Sasaki Y, Sugai T, Tokino T, Hiratsuka H, Suzuki H.

Cell Death Dis. 2018 Aug 1;9(8):826. doi: 10.1038/s41419-018-0893-2.

15.

Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment.

Wakasugi H, Takahashi H, Niinuma T, Kitajima H, Oikawa R, Matsumoto N, Takeba Y, Otsubo T, Takagi M, Ariizumi Y, Suzuki M, Okuse C, Iwabuchi S, Nakano M, Akutsu N, Kang JH, Matsui T, Yamada N, Sasaki H, Yamamoto E, Kai M, Sasaki Y, Sasaki S, Tanaka Y, Yotsuyanagi H, Tsutsumi T, Yamamoto H, Tokino T, Nakase H, Suzuki H, Itoh F.

Cancer Lett. 2018 Oct 10;434:91-100. doi: 10.1016/j.canlet.2018.07.019. Epub 2018 Jul 17.

PMID:
30026054
16.

Efficacy and Safety of Bi-weekly Pegfilgrastim for Dose-dense Chemotherapy-induced Neutropenia in Breast Cancer Patients.

Mori H, Kubo M, Kai M, Kurata K, Yamada M, Nakamura M.

Anticancer Res. 2018 Jul;38(7):4381-4386. doi: 10.21873/anticanres.12740.

PMID:
29970577
17.

Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines.

Kubo M, Umebayashi M, Kurata K, Mori H, Kai M, Onishi H, Katano M, Nakamura M, Morisaki T.

Anticancer Res. 2018 Jul;38(7):4273-4279. doi: 10.21873/anticanres.12724.

PMID:
29970561
18.

Visualizing Energy Charge in Breast Carcinoma Tissues by MALDI Mass-spectrometry Imaging Profiles of Low-molecular-weight Metabolites.

Torata N, Kubo M, Miura D, Ohuchida K, Mizuuchi Y, Fujimura Y, Hayakawa E, Kai M, Oda Y, Mizumoto K, Hashizume M, Nakamura M.

Anticancer Res. 2018 Jul;38(7):4267-4272. doi: 10.21873/anticanres.12723.

PMID:
29970560
19.

Surface microstructures are associated with mutational intratumoral heterogeneity in colorectal tumors.

Harada T, Yamamoto E, Yamano HO, Aoki H, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Tanaka Y, Yoshida Y, Eizuka M, Yorozu A, Sudo G, Kitajima H, Niinuma T, Kai M, Sasaki Y, Tokino T, Sugai T, Nakase H, Suzuki H.

J Gastroenterol. 2018 Dec;53(12):1241-1252. doi: 10.1007/s00535-018-1481-z. Epub 2018 Jun 11.

PMID:
29948303
20.

BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations.

Mori H, Kubo M, Kai M, Velasquez VV, Kurata K, Yamada M, Okido M, Kuroki S, Oda Y, Nakamura M.

Clin Breast Cancer. 2018 Oct;18(5):e1217-e1227. doi: 10.1016/j.clbc.2018.05.008. Epub 2018 Jun 2.

21.

Biodistribution and Toxicity of Micellar Platinum Nanoparticles in Mice via Intravenous Administration.

Brown AL, Kai MP, DuRoss AN, Sahay G, Sun C.

Nanomaterials (Basel). 2018 Jun 7;8(6). pii: E410. doi: 10.3390/nano8060410.

22.

Authors' Reply.

Kai M, Tasaki M, Chino N.

J Minim Invasive Gynecol. 2018 Nov - Dec;25(7):1311. doi: 10.1016/j.jmig.2018.05.019. Epub 2018 May 28. No abstract available.

PMID:
29852295
23.

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer.

Shindo T, Niinuma T, Nishiyama N, Shinkai N, Kitajima H, Kai M, Maruyama R, Tokino T, Masumori N, Suzuki H.

Oncotarget. 2018 May 11;9(36):24457-24469. doi: 10.18632/oncotarget.25326. eCollection 2018 May 11.

24.

Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.

Aoki H, Yamamoto E, Yamano HO, Sugai T, Kimura T, Tanaka Y, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Nakaoka M, Yoshida Y, Harada T, Sudo G, Eizuka M, Yorozu A, Kitajima H, Niinuma T, Kai M, Nojima M, Suzuki H, Nakase H.

Dig Dis Sci. 2018 Jul;63(7):1920-1928. doi: 10.1007/s10620-018-5016-5. Epub 2018 Mar 15.

PMID:
29546645
25.

Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.

Cambau E, Saunderson P, Matsuoka M, Cole ST, Kai M, Suffys P, Rosa PS, Williams D, Gupta UD, Lavania M, Cardona-Castro N, Miyamoto Y, Hagge D, Srikantam A, Hongseng W, Indropo A, Vissa V, Johnson RC, Cauchoix B, Pannikar VK, Cooreman EAWD, Pemmaraju VRR, Gillini L; WHO surveillance network of antimicrobial resistance in leprosy.

Clin Microbiol Infect. 2018 Dec;24(12):1305-1310. doi: 10.1016/j.cmi.2018.02.022. Epub 2018 Mar 1.

26.

Clinical Features and Surgical Management of Cerebellopontine Angle Cholesteatoma That Presented as Trigeminal Neuralgia.

Kai M, Yongjie L.

World Neurosurg. 2018 Jul;115:e7-e12. doi: 10.1016/j.wneu.2018.02.047. Epub 2018 Feb 15.

PMID:
29454958
27.

Evolutionary stability of antibiotic protection in a defensive symbiosis.

Engl T, Kroiss J, Kai M, Nechitaylo TY, Svatoš A, Kaltenpoth M.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2020-E2029. doi: 10.1073/pnas.1719797115. Epub 2018 Feb 14.

28.

Epigenetic silencing of SMOC1 in traditional serrated adenoma and colorectal cancer.

Aoki H, Yamamoto E, Takasawa A, Niinuma T, Yamano HO, Harada T, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Tanaka Y, Yoshida Y, Aoyama T, Eizuka M, Yorozu A, Kitajima H, Kai M, Sawada N, Sugai T, Nakase H, Suzuki H.

Oncotarget. 2017 Dec 20;9(4):4707-4721. doi: 10.18632/oncotarget.23523. eCollection 2018 Jan 12.

29.

Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae.

Benjak A, Avanzi C, Singh P, Loiseau C, Girma S, Busso P, Fontes ANB, Miyamoto Y, Namisato M, Bobosha K, Salgado CG, da Silva MB, Bouth RC, Frade MAC, Filho FB, Barreto JG, Nery JAC, Bührer-Sékula S, Lupien A, Al-Samie AR, Al-Qubati Y, Alkubati AS, Bretzel G, Vera-Cabrera L, Sakho F, Johnson CR, Kodio M, Fomba A, Sow SO, Gado M, Konaté O, Stefani MMA, Penna GO, Suffys PN, Sarno EN, Moraes MO, Rosa PS, Baptista IMFD, Spencer JS, Aseffa A, Matsuoka M, Kai M, Cole ST.

Nat Commun. 2018 Jan 24;9(1):352. doi: 10.1038/s41467-017-02576-z.

30.

Bioderived DNA Nanomachines for Potential Uses in Biosensing, Diagnostics, and Therapeutic Applications.

Angell C, Kai M, Xie S, Dong X, Chen Y.

Adv Healthc Mater. 2018 Apr;7(8):e1701189. doi: 10.1002/adhm.201701189. Epub 2018 Jan 19. Review.

PMID:
29350489
31.

Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: A 2-Center Prospective Study.

Shindo T, Shimizu T, Nojima M, Niinuma T, Maruyama R, Kitajima H, Kai M, Itoh N, Suzuki H, Masumori N.

Urology. 2018 Mar;113:71-78. doi: 10.1016/j.urology.2017.11.025. Epub 2017 Nov 28.

PMID:
29196070
32.

Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors.

Niinuma T, Kai M, Kitajima H, Yamamoto E, Harada T, Maruyama R, Nobuoka T, Nishida T, Kanda T, Hasegawa T, Tokino T, Sugai T, Shinomura Y, Nakase H, Suzuki H.

Oncol Lett. 2017 Nov;14(5):5703-5710. doi: 10.3892/ol.2017.6911. Epub 2017 Sep 8.

33.

Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant.

Hsu PY, Wu VS, Kanaya N, Petrossian K, Hsu HK, Nguyen D, Schmolze D, Kai M, Liu CY, Lu H, Chu P, Vito CA, Kruper L, Mortimer J, Chen S.

Clin Cancer Res. 2018 Jan 15;24(2):395-406. doi: 10.1158/1078-0432.CCR-17-1983. Epub 2017 Oct 27.

PMID:
29079660
34.

Evaluation of a Spray-type, Novel Dextrin Hydrogel Adhesion Barrier Under Laparoscopic Conditions in a Porcine Uterine Horn Adhesion Model.

Kai M, Maeda K, Tasaki M, Kira S, Nakamura S, Chino N, Hagiwara H, Nishida H, Kawanishi T.

J Minim Invasive Gynecol. 2018 Mar - Apr;25(3):447-454. doi: 10.1016/j.jmig.2017.09.023. Epub 2017 Oct 10.

PMID:
29030291
35.

[Efficacy of GC Therapy for the Patient of iTNBC with Resistance to TAC Therapy].

Yamada M, Kubo M, Kai M, Yamamoto H, Nakamura M.

Gan To Kagaku Ryoho. 2017 Aug;44(8):703-705. Japanese.

PMID:
28860445
36.

Malperfusion in Type A Dissection: Consider Reperfusion First.

Goldberg JB, Lansman SL, Kai M, Tang GHL, Malekan R, Spielvogel D.

Semin Thorac Cardiovasc Surg. 2017 Summer;29(2):181-185. doi: 10.1053/j.semtcvs.2016.10.017. Epub 2016 Nov 11. Review.

PMID:
28823325
37.

Pharmacoresistant epileptic eyelid twitching in a child with a mutation in SYNGAP1.

Okazaki T, Saito Y, Hiraiwa R, Saitoh S, Kai M, Adachi K, Nishimura Y, Nanba E, Maegaki Y.

Epileptic Disord. 2017 Sep 1;19(3):339-344. doi: 10.1684/epd.2017.0922.

38.

Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.

Borsoi C, Leonard F, Lee Y, Zaid M, Elganainy D, Alexander JF, Kai M, Liu YT, Kang Y, Liu X, Koay EJ, Ferrari M, Godin B, Yokoi K.

Cancer Lett. 2017 Sep 10;403:296-304. doi: 10.1016/j.canlet.2017.06.026. Epub 2017 Jul 4.

39.

Versatile DNA Origami Nanostructures in Simplified and Modular Designing Framework.

Cui Y, Chen R, Kai M, Wang Y, Mi Y, Wei B.

ACS Nano. 2017 Aug 22;11(8):8199-8206. doi: 10.1021/acsnano.7b03187. Epub 2017 Jul 6.

PMID:
28654269
40.

Effects of discrete bioactive microbial volatiles on plants and fungi.

Piechulla B, Lemfack MC, Kai M.

Plant Cell Environ. 2017 Oct;40(10):2042-2067. doi: 10.1111/pce.13011. Epub 2017 Aug 24. Review.

PMID:
28643880
41.

Tumor progression effects on drug vector access to tumor-associated capillary bed.

Kiseliovas V, Milosevic M, Kojic M, Mazutis L, Kai M, Liu YT, Yokoi K, Ferrari M, Ziemys A.

J Control Release. 2017 Sep 10;261:216-222. doi: 10.1016/j.jconrel.2017.05.031. Epub 2017 May 31.

PMID:
28576640
42.

Exploring bacterial interspecific interactions for discovery of novel antimicrobial compounds.

Tyc O, de Jager VCL, van den Berg M, Gerards S, Janssens TKS, Zaagman N, Kai M, Svatos A, Zweers H, Hordijk C, Besselink H, de Boer W, Garbeva P.

Microb Biotechnol. 2017 Jul;10(4):910-925. doi: 10.1111/1751-7915.12735. Epub 2017 May 29.

43.

A lard-rich high-fat diet increases hepatic peroxisome proliferator-activated receptors in endotoxemic rats.

Kai M, Miyoshi M, Fujiwara M, Nishiyama Y, Inoue T, Maeshige N, Hamada Y, Usami M.

J Surg Res. 2017 May 15;212:22-32. doi: 10.1016/j.jss.2016.11.048. Epub 2016 Dec 7.

PMID:
28550910
44.

RNA-binding protein RBM14 regulates dissociation and association of non-homologous end joining proteins.

Simon NE, Yuan M, Kai M.

Cell Cycle. 2017 Jun 18;16(12):1175-1180. doi: 10.1080/15384101.2017.1317419. Epub 2017 Apr 20.

45.

Establishment of a new initial dose plan for vancomycin using the generalized linear mixed model.

Kourogi Y, Ogata K, Takamura N, Tokunaga J, Setoguchi N, Kai M, Tanaka E, Chiyotanda S.

Theor Biol Med Model. 2017 Apr 8;14(1):8. doi: 10.1186/s12976-017-0054-9.

46.

Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.

Kai M, Yamamoto E, Sato A, Yamano HO, Niinuma T, Kitajima H, Harada T, Aoki H, Maruyama R, Toyota M, Hatahira T, Nakase H, Sugai T, Yamashita T, Toyota M, Suzuki H.

Mol Carcinog. 2017 Jul;56(7):1743-1752. doi: 10.1002/mc.22631. Epub 2017 Mar 6.

PMID:
28218473
47.

Rikkunshito prevents paclitaxel-induced peripheral neuropathy through the suppression of the nuclear factor kappa B (NFκB) phosphorylation in spinal cord of mice.

Kamei J, Hayashi S, Sakai A, Nakanishi Y, Kai M, Ikegami M, Ikeda H.

PLoS One. 2017 Feb 9;12(2):e0171819. doi: 10.1371/journal.pone.0171819. eCollection 2017.

48.

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer.

Mori H, Kubo M, Yamaguchi R, Nishimura R, Osako T, Arima N, Okumura Y, Okido M, Yamada M, Kai M, Kishimoto J, Oda Y, Nakamura M.

Oncotarget. 2017 Feb 28;8(9):15584-15592. doi: 10.18632/oncotarget.14698.

49.

Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker.

Yin S, Kabashima T, Zhu Q, Shibata T, Kai M.

Sci Rep. 2017 Jan 13;7:40670. doi: 10.1038/srep40670.

50.

More Attention Should Be Paid to Abnormalities of Circadian Blood Pressure Rhythm in Heart Failure Patients.

Kai M, Kai H.

Circ J. 2017 Jan 25;81(2):153-154. doi: 10.1253/circj.CJ-16-1269. Epub 2016 Dec 28. No abstract available.

Supplemental Content

Support Center